PatternsRadar
Sign in

CORONACORONA Remedies Limited

NSE
2,263.20INR+26.50 (+1.18%)Close · 20 Nov 2026
30 Oct 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹13,842 CrMarket cap
66.9P/E (TTM)
21.9%Delivery

Filings & corporate actions

5 results filed
CSV
Next results · Q3 FY27
Expected 30 Jan 2027 – 7 Apr 2027
Estimate: filed 30–97 days after quarter end, last 5 times
Dividend
₹10.00 per share · last 19 Jun 2026
2026
  • 30 OctresultsResults · Q2 FY27 · consolidated and standalone+1.0%NSE
  • 7 OctshareholdingShareholding · 30 Sept 2026+0.1%NSE
  • 31 JulresultsResults · Q1 FY27 · consolidated and standalone+0.3%NSE
  • 13 JulshareholdingShareholding · 30 Jun 2026+0.6%NSE
  • 19 JundividendDividend · ₹10.00 per share+1.8%
  • 11 MayresultsResults · Q4 FY26 · consolidated and standalone-7.1%NSE
  • 17 AprshareholdingShareholding · 31 Mar 2026+2.8%NSE
  • 2 FebresultsResults · Q3 FY26 · consolidated and standalone+2.9%NSE
  • 20 JanshareholdingShareholding · 31 Dec 2025-3.1%NSE
  • 5 JanresultsResults · Q2 FY26 · consolidated and standalone+1.6%NSE

Reaction to results · all yearsrose on day 0 in 4 of 5 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY2730 Oct 2026+1.0%+17.9%—1.5×
Q1 FY2731 Jul 2026+0.3%-0.8%-2.3%4.4×
Q4 FY2611 May 2026-7.1%+1.5%-1.2%9.4×
Q3 FY262 Feb 2026+2.9%+11.9%+5.9%0.6×
Q2 FY265 Jan 2026+1.6%-3.0%+4.0%—
Average-0.2%+5.5%+1.6%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY+22.2%
Profit YoY+15.3%
Interest cost YoY—
Revenue QoQ+4.4%
Profit QoQ+0.3%
CAGR2Y3Y4Y5Y6Y7Y
Revenue——————
Profit——————

Key data

Open2,235.10
Day range2,228.00 – 2,364.50
52-week range—
From 52w high—
RSI (14)51.2
ATR (14)101.98
Volume1.77L
Avg volume (20D)69.1K
Rel volume2.56×
Volatility (1Y)33.2%
Turnover₹40.8Cr
Traded value (NSE)₹40.8Cr
VWAP2,310.17
SMA 50 / 2002,173.58 / 1,890.25
Price band20%

Delivery percentage

Latest · 20 Nov 202621.9%
20-day avg43.2%
1-year avg46.3%
Percentile (own history)4th
Range15.3–87.0%
Sessions232

Over the last 20 sessions CORONA settled 43.2% of its traded quantity, which is ordinary for an NSE equity. Its one-year average is 46.3%, so recent sessions are running 3.1 points lower than usual.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.44%
Dividend, trailing 12M₹10.00
Paid every year for1 yr
Shareholders21.1K · +4.5% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy156 days ago

Performance returns

1D1W1M3M6M1Y
Price+1.18%-2.85%+10.73%+4.50%+32.63%—

Valuation

Market cap₹13,842 Cr
Market cap (NSE)₹13,842 Cr
Free-float cap₹4,291 Cr
P/E (TTM)66.9
P/E (NSE)66.1
EPS (TTM)33.85
P/B17.2
Net margin (TTM)13.3%
Other income / PBT4.4%
ROE28.3%
Debt / equity0.12
Shares outstanding6.12Cr
Listed15 Dec 2025

Ownership

Promoter69.00%
Promoter Δ QoQ0.00 pp
Public31.00%
FII4.21%
DII16.45%
Pledged0.00%

Quarterly results · consolidated

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)342.4353.1422.4441.2
YoY chg———+22.2%
Net profit (₹ Cr)41.345.360.160.3
YoY chg———+15.3%
Net margin12.1%12.8%14.2%13.7%
EPS6.757.419.839.86

Shareholding over time

By quarter

30 Sept 2026 · promoter 69.00% · public 31.00%
13 Dec 2025: promoter 69.00%31 Dec 2025: promoter 69.00%31 Mar 2026: promoter 69.00%30 Jun 2026: promoter 69.00%30 Sept 2026: promoter 69.00%
2025-122026-09
  • Promoter
  • Public and others
Promoter
69.00%
Public
31.00%
Promoter change
0.00 pp
Filed
7 Oct 2026
FII
4.21%
DII
16.45%
Promoter pledged
0.00%

Who the public is

Mutual funds
16.06%

+3.56 pp QoQ

Insurance
0.25%

-0.04 pp QoQ

FPI
4.21%

+0.58 pp QoQ

Retail ≤ ₹2L
1.03%

+0.18 pp QoQ

HNI > ₹2L
0.00%

-0.04 pp QoQ

NRI
0.02%

+0.01 pp QoQ

Bodies corporate
0.45%

-0.14 pp QoQ

Shareholders
21,098

+4.5% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
NIRAV KIRTIKUMAR MEHTAPromoter · Individual22.00%
ANKURBHAI K MEHTAPromoter · Individual22.00%
KIRTIKUMAR LAXMIDAS MEHTAPromoter · Individual20.00%
SEPIA INVESTMENTS LIMITEDCorporate8.62%
INVESCO INDIA SMALL CAP FUNDMutual fund5.26%
HDFC TRUSTEE COMPANY LIMITED-HDFC FLEXI CAP FUNDMutual fund4.10%
SBI RETIREMENT BENEFIT FUND- CONSERVATIVE PLANMutual fund3.57%
DIPABEN NIRAVKUMAR MEHTAPromoter · Individual2.00%
BRINDA ANKUR MEHTAPromoter · Individual2.00%
MINAXI KIRTIKUMAR MEHTAPromoter · Individual1.00%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Dividends

since 19 Jun 2026 CSV
Financial yearPaymentsDeclaredAdjusted
FY2026-271₹10.00₹10.00
Ex-dateRecord dateDeclaredAdjusted
19 Jun 2026—₹10.00₹10.00

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

52-week highs & lows

Loading…

Each session the stock traded past its previous 52-week high or low, from NSE's daily report; the previous figure is the record it broke. Prices as published, not split-adjusted.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
₹0
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
none on record
Disclosures on record
14
14 open-market of the newest 14
By year
BroadcastPersonSideSharesValuePriceHolding before → afterStakeRegulation
19 Aug 2026Kirtisinh Manoharsinh ParmarRelativeBuy1₹2,0822,082.00245 → 2460.00%0.00 pp7(2)told 18 Aug 2026
19 Aug 2026Kirtisinh Manoharsinh ParmarRelativeBuy48₹99,4722,072.33197 → 2450.00%0.00 pp7(2)told 18 Aug 2026
19 Aug 2026Kirtisinh Manoharsinh ParmarRelativeBuy6₹12,4942,082.33191 → 1970.00%0.00 pp7(2)told 18 Aug 2026
19 Aug 2026Kirtisinh Manoharsinh ParmarRelativeBuy35₹73,4112,097.46156 → 1910.00%0.00 pp7(2)told 18 Aug 2026
19 Aug 2026Kirtisinh Manoharsinh ParmarRelativeBuy50₹1.1L2,122.52106 → 1560.00%0.00 pp7(2)told 18 Aug 2026
19 Aug 2026Kirtisinh Manoharsinh ParmarRelativeBuy50₹1.1L2,142.5656 → 1060.00%0.00 pp7(2)told 18 Aug 2026
19 Aug 2026Apurvsinh Kirtisinh ParmarEmployeeBuy50₹1.0L2,064.54100 → 1500.00%0.00 pp7(2)told 18 Aug 2026
19 Aug 2026Apurvsinh Kirtisinh ParmarEmployeeBuy50₹1.1L2,104.8450 → 1000.00%0.00 pp7(2)told 18 Aug 2026
19 Aug 2026Ranjanben Kirtisinh ParmarRelativeBuy75₹1.6L2,089.7390 → 1650.00%0.00 pp7(2)told 18 Aug 2026
19 Aug 2026Ranjanben Kirtisinh ParmarRelativeBuy90₹1.9L2,119.920 → 900.00%0.00 pp7(2)told 18 Aug 2026
19 Aug 2026Kirtisinh Manoharsinh ParmarRelativeBuy43₹89,5422,082.37298 → 3410.00%0.00 pp7(2)told 18 Aug 2026
19 Aug 2026Kirtisinh Manoharsinh ParmarRelativeBuy2₹4,1452,072.50296 → 2980.00%0.00 pp7(2)told 18 Aug 2026
19 Aug 2026Kirtisinh Manoharsinh ParmarRelativeBuy50₹1.0L2,092.40246 → 2960.00%0.00 pp7(2)told 18 Aug 2026
19 Aug 2026Apurvsinh Kirtisinh ParmarEmployeeBuy50₹1.1L2,135.020 → 500.00%0.00 pp7(2)told 18 Aug 2026

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Filings

CSV
Loading…

Bulk & block deals · 17 Jun 2026

CSV
12 of 22 deals
By year
DateDealClientQuantityPriceValue
17 Jun 2026Sell · block, also bulkSEPIA INVESTMENTS LIMITED43.29L1,730.00₹748.9Cr
17 Jun 2026Buy · blockHDFC MUTUAL FUND24.50L1,730.00₹423.9Cr
17 Jun 2026Buy · blockADITYA BIRLA SUN LIFE MUTUAL FUND4.90L1,730.00₹84.8Cr
17 Jun 2026Buy · block, also bulkABERDEEN ASIAN SMALLER COMPANIES INVESTMENT TRUST PLC4.51L1,730.00₹78.0Cr
17 Jun 2026Buy · blockINVESCO MUTUAL FUND2.89L1,730.00₹50.0Cr
17 Jun 2026Buy · blockABERDEEN STANDARD SICAV I - ASIAN SMALLER COMPANIES FUND2.74L1,730.00₹47.4Cr
17 Jun 2026Sell · blockANCHOR PARTNERS1.62L1,730.00₹28.0Cr
17 Jun 2026Buy · blockKOTAK MAHINDRA MUTUAL FUND1.62L1,730.00₹28.0Cr
17 Jun 2026Buy · blockINDIA ACORN ICAV - ASHOKA WHITEOAK EMERGING MARKETS EQUITY FUND1.49L1,730.00₹25.7Cr
17 Jun 2026Buy · blockWHITEOAK CAPITAL MUTUAL FUND1.45L1,730.00₹25.1Cr
17 Jun 2026Buy · blockABU DHABI INVESTMENT AUTHORITY - WAY39.1K1,730.00₹6.8Cr
17 Jun 2026Buy · blockASHOKA WHITEOAK EMERGING MARKETS EQUITY EX CHINA FUND29.5K1,730.00₹5.1Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.

Exchange surveillance

20 Nov 2026
  • P/E > 50 (4 quarters) · since 28 Apr 2026 — P/E above 50 on the last four quarters’ earnings.

Price band: 20% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures.

Every stock on this session →

Financials · quarterly statement

₹ crore, as filed
By year
 Q2 FY26Q3 FY26Q4 FY26AQ1 FY27Q2 FY27
Revenue from operations361.1342.4353.1422.4441.2
Other income2.32.24.13.22.5
Total income363.4344.7357.2425.6443.7
Total expenses293.8270.4302.7345.2363.0
└ Finance costs1.91.71.42.72.8
└ Depreciation9.29.510.313.215.1
Profit before tax69.655.254.780.480.6
Tax expense17.513.99.420.320.4
Net profit52.341.345.360.160.3
EPS8.556.757.419.839.86
Net margin14.49%12.05%12.84%14.23%13.67%
PBT margin19.28%16.12%15.50%19.02%18.27%
Tax rate25.08%25.25%17.19%25.20%25.35%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 30 Oct 2026.

Balance sheet & cash flow · half-yearly

₹ crore, as filed
By year

Balance sheet

 H1 FY26FY26H1 FY27
Total assets976.61,205.11,246.7
Current assets345.9348.3473.7
└ Cash & equivalents1.81.81.6
└ Other bank balances52.242.397.2
└ Current investments0.00.00.0
└ Trade receivables160.1145.6170.6
└ Inventories107.3125.0170.7
Total equity659.7746.9805.1
└ Attributable to owners659.7746.9805.1
└ Share capital61.261.261.2
Borrowings39.6142.994.5
└ Current39.6142.994.3
└ Non-current0.00.00.3
Trade payables140.8147.1115.7
Current liabilities242.4361.2333.0
Total liabilities317.0458.3441.6
Net debt(14.4)98.7(4.3)
Debt / equity0.060.190.12
Current ratio1.430.961.42

Cash flow, year to date

 H1 FY26FY26H1 FY27
Operating cash flow113.4229.5112.7
└ Capex(32.5)(174.1)(26.3)
Free cash flow80.955.386.4
Investing cash flow(41.3)(256.2)3.3
Financing cash flow(73.6)25.3(116.3)
└ Dividends paid(44.7)0.0(61.2)
└ Buybacks0.00.00.0
Net change in cash(1.4)(1.4)(0.3)

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

CORONA at a glance

  • CORONA closed at ₹2,263.2 on 20 Nov 2026, +1.18% on the day.
  • Delivery was 21.9% of traded quantity on 20 Nov 2026, the 4th percentile of its own 232 sessions with a reading (20-session average 43.2%, 1-year average 46.3%).
  • Market capitalisation is ₹13,842 crore at a trailing P/E of 66.9 (trailing EPS ₹33.85).
  • Q2 FY27 results (consolidated, filed 30 Oct 2026): revenue ₹441 crore (+22.2% year on year), net profit ₹60 crore (+15.3%); the price moved +1.0% on the first session after.
  • Promoters held 69.00% at 30 Sept 2026, unchanged on the previous filing.
  • Q3 FY27 results are expected between 30 Jan 2027 and 7 Apr 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE02ZQ01018
SeriesEQ
Listed15 Dec 2025
IPO price1,062.00 · band Rs.1008 to Rs.1062
IPO listing15 Dec 2025
NSE market cap · 17 Nov 2026₹13,918 Cr
Free-float market cap (NSE)₹2,550 Cr
Shares outstanding (NSE)6.12Cr
History from15 Dec 2025
Sessions232
Turnover rank#802

Sector history

  1. to 16 Aug 2026Index industry · Healthcare
  2. from 16 Aug 2026Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

NSE’s own classification, by the snapshot it changed on.

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.